CAS: 318250-11-2 - P1-(2'-Deoxycytidin-5'-yl)-P4-(uridin-5'-yl)tetraphosphate tetrasodium salt

Fórmula: C₁₈H₂₃N₅Na₄O₂₁P₄

InChI: InChI=1/C18H27N5O21P4.4Na/c19-11-1-3-22(17(28)20-11)13-5-8(24)9(40-13)6-38-45(30,31)42-47(34,35)44-48(36,37)43-46(32,33)39-7-10-14(26)15(27)16(41-10)23-4-2-12(25)21-18(23)29;;;;/h1-4,8-10,13-16,24,26-27H,5-7H2,(H,30,31)(H,32,33)(H,34,35)(H,36,37)(H2,19,20,28)(H,21,25,29);;;;/q;4*+1/p-4/t8-,9+,10+,13+,14+,15+,16+;;;;/m0..../s1

Sinónimos:

• Denufosol tetrasodium
• dCp4U
• Ins-37217
• Uridine 5'-(pentahydrogen tetraphosphate) P'''--5'-ester with 2'-deoxycytidine tetrasodium salt
• tetrasodium [[[[(3S,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3-hydroxy-tetrahydrofuran-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl] [(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl hydrogen phosphate
• tetrasodium [[[[(2R,3S,5R)-5-(4-amino-2-oxo-pyrimidin-1-yl)-3-hydroxy-tetrahydrofuran-2-yl]methoxy-oxido-phosphoryl]oxy-oxido-phosphoryl]oxy-oxido-phosphoryl] [(2R,3S,4R,5R)-5-(2,4-dioxopyrimidin-1-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methyl phosphate

Denufosol tetrasodium

CAS: 318250-11-2

Denufosol is a P2Y2 agonist potentially for the treatment of cystic fibrosis.

• Fórmula: C₁₈H₂₃N₅Na₄O₂₁P₄
• Pureza: 98%
• Cor e Forma: Solid
• Peso molecular: 861.25

Denufosol tetrasodium

CAS: 318250-11-2

A P2Y2 receptor agonist that has been studied in cystic fibrosis and retinal diseases such …

• Fórmula: C₁₈H₂₃N₅Na₄O₂₁P₄
• Pureza: Min. 90 Area-%
• Cor e Forma: Powder
• Peso molecular: 861.25 g/mol